COR

Cencora, Inc.NYSEHealthcare

$324.80+2.25%OpenMarket Cap: $63.18B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-13	Barclays	—	Overweight	—
2026-02-10	JP Morgan	—	Overweight	—
2026-02-10	Wells Fargo	—	Overweight	—
2026-02-05	Evercore ISI Group	—	Outperform	—
2026-01-29	Morgan Stanley	—	Overweight	—
2026-01-22	Jefferies	—	Buy	—
2026-01-05	B of A Securities	—	Neutral	—
2025-11-11	JP Morgan	—	Overweight	—
2025-11-11	Wells Fargo	—	Overweight	—
2025-11-10	TD Cowen	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Sep 30	$19.57	$369.22B	8
Sat Sep 30	$21.70	$395.04B	4
Sun Sep 30	$24.52	$434.52B	1
Mon Sep 30	$27.61	$481.62B	1